Select Page

Did you miss our second episode of DoctoLIVE which took place on Tuesday 14th September, 2021? You can now fill in the form to get access to the recording! 👉

Our AplusA expert, Siegfried ERTL and Dr. GERL, a German hemato-oncologist, were discussing how patients are considered for referral, patient eligibility to receive CAR-T therapy, barriers to treatment, unmet needs and much more.

Dr GERL is a hematological oncologist with office in central Munich. He treats over 800 patients in many hematological and oncological conditions. He also holds a teaching position at the LMU in Munich. Dr. GERL has access to CAR-T treatments and regularly refers patient to a CAR-T center.

What is DoctoLIVE?
DoctoLIVE is your window to real-world challenges in real-life healthcare practice, from an actual healthcare practioner's perspective.
DoctoLIVE offers you a 15-minute open-mic discussion featuring a different HCP every session, answering your questions related to real-life treatment experiences, all organized by AplusA. These discussions will be held in English.
We will cover how to implement new therapeutics in actual practice, uncover pain points and discuss areas for improvement.

Register now for the upcoming episodes!